Biodel (BIOD)

Add to Watchlists
Create an Alert
2.39 -0.07  -2.85% NASDAQ Apr 24, 8:00PM BATS Real time Currency in USD
View Full Chart
BIOD Price Chart
View All Events

BIOD Events

Date Type Description
Mar 04 Misc AGM Event for Biodel Inc
Feb 06 Misc Q1 2014 Biodel Earnings Call
Feb 06 Earnings Q1 2014 Biodel Earnings Results. Estimate: -0.18.
Dec 18 Misc Biodel Fourth Quarter 2013 Earnings Call
Dec 18 Earnings Biodel to Report Fourth Quarter Fiscal Year 2013 Financial Results on December 18, 2013. Estimate: -0.30.
Sep 09 Misc Biodel's Study 3-201top Line Data Conference Call
Aug 12 Misc Biodel Third Quarter 2013 Earnings Call
Aug 12 Earnings Biodel to Report Third Quarter Fiscal Year 2013 Financial Results on August 12, 2013. Estimate: -0.37.
May 08 Misc Biodel Second Quarter 2013 Earnings Call
May 08 Earnings Biodel Second Quarter 2013 Earnings Call. Estimate: -0.42.
View All Performance Charts

BIOD Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Biodel is down 20.33% over the last year vs S&P 500 Total Return up 21.54%, Endocyte up 33.93%, and ARIAD Pharmaceuticals down 59.97%.

Get Quote for

Portfolio Strategies Featuring BIOD

Did Biodel make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

BIOD Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: Connecticut
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: September 30, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Biodel, Inc., is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes.

Recent Quotes

Symbol Price Chg Chg % Market Cap
BIOD 2.39 -0.07 -2.85% 50.37M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.